Dallah Healthcare Company (4004.SR)
Saudi - Saudi Delayed price. Currency in SAR
Add to watchlist
At close: 03:16PM AST
Currency in SAR
Valuation measures4
| Market cap (intra-day) | 15.52B |
| Enterprise value | 17.22B |
| Trailing P/E | 40.36 |
| Forward P/E | 37.04 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.16 |
| Price/book (mrq) | 4.67 |
| Enterprise value/revenue | 5.72 |
| Enterprise value/EBITDA | 26.15 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.20 |
| 52-week change 3 | -5.24% |
| S&P500 52-week change 3 | 23.20% |
| 52-week high 3 | 194.00 |
| 52-week low 3 | 131.40 |
| 50-day moving average 3 | 165.28 |
| 200-day moving average 3 | 163.93 |
Share statistics
| Avg vol (3-month) 3 | 76.51k |
| Avg vol (10-day) 3 | 89.77k |
| Shares outstanding 5 | 97.59M |
| Implied shares outstanding 6 | 99.69M |
| Float 8 | 40.94M |
| % held by insiders 1 | 58.06% |
| % held by institutions 1 | 4.06% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 2 |
| Forward annual dividend yield 4 | 1.26% |
| Trailing annual dividend rate 3 | 1.50 |
| Trailing annual dividend yield 3 | 0.95% |
| 5-year average dividend yield 4 | 1.70 |
| Payout ratio 4 | 50.76% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 17 Jan 2024 |
| Last split factor 2 | 6:5 |
| Last split date 3 | 14 Sept 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 12.78% |
| Operating margin (ttm) | 19.03% |
Management effectiveness
| Return on assets (ttm) | 5.25% |
| Return on equity (ttm) | 11.78% |
Income statement
| Revenue (ttm) | 3.01B |
| Revenue per share (ttm) | 30.82 |
| Quarterly revenue growth (yoy) | 9.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 626.21M |
| Net income avi to common (ttm) | 384.76M |
| Diluted EPS (ttm) | 3.94 |
| Quarterly earnings growth (yoy) | 26.00% |
Balance sheet
| Total cash (mrq) | 213.64M |
| Total cash per share (mrq) | 2.19 |
| Total debt (mrq) | 1.92B |
| Total debt/equity (mrq) | 53.33% |
| Current ratio (mrq) | 1.22 |
| Book value per share (mrq) | 34.02 |
Cash flow statement
| Operating cash flow (ttm) | 723.64M |
| Levered free cash flow (ttm) | 147.29M |
© 2024 Yahoo. All rights reserved.